Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 649,729 | 638,476 | 610,820 | 681,184 | 632,124 |
| Cost of Goods | 293,826 | 283,357 | 284,854 | 314,821 | 296,441 |
| Gross Profit | 355,903 | 355,119 | 325,966 | 366,363 | 335,683 |
| Operating Expenses | 292,263 | 253,980 | 282,112 | 271,867 | 245,175 |
| Operating Income | 64,466 | 101,496 | 44,708 | 95,317 | 90,949 |
| Interest Expense | 12,174 | 12,264 | 12,277 | 12,361 | 12,398 |
| Other Income | 809,328 | -2,875,513 | 458,647 | 345,436 | 58,551 |
| Pre-tax Income | 861,620 | -2,786,281 | 491,078 | 428,392 | 137,102 |
| Income Tax | 208,448 | -620,795 | 107,162 | 78,684 | 30,845 |
| Net Income Continuous | 653,172 | -2,165,486 | 383,916 | 349,708 | 106,257 |
| Net Income | $653,172 | $-2,165,486 | $383,916 | $349,708 | $106,257 |
| EPS Basic Total Ops | 23.37 | -76.26 | 13.46 | 11.79 | 3.65 |
| EPS Basic Continuous Ops | 23.37 | -76.26 | 13.46 | 11.79 | 3.65 |
| EPS Diluted Total Ops | 23.34 | -76.26 | 13.45 | 11.81 | 3.64 |
| EPS Diluted Continuous Ops | 23.34 | -76.26 | 13.45 | 11.82 | 3.64 |
| EPS Diluted Before Non-Recurring Items | 2.01 | 3.11 | 2.29 | 3.10 | 2.33 |
| EBITDA(a) | $64,466 | $101,496 | $44,708 | $95,317 | $90,949 |